ArticleAmerican journal of obstetrics and gynecology2018

Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohort.

Paul F Pinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.